CANSINOBIO 06185Hong Kong Stock Exchange

35.0202.61%( -0.940 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
CANSINOBIO (06185) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2019-03-28
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100003F01
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)1.24B50/112
Net Profit (Last FY)32.69M51/125
ROE (Last FY)0.56%52/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Xuefeng YU Executive Director
Shou Bai CHAO Executive Director
Jing WANG Executive Director
Chi Shing LI Executive Director
Yiu Leung Andy CHEUNG Executive Director
Man CHO Executive Director
Xuefeng JI Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-11-27.

About this page

This page shows CANSINOBIO (06185) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.